Medtronic remains a dependable dividend aristocrat, but its long-term total shareholder returns lag significantly behind ...

Protagonist Therapeutics' partners ought to secure two approvals for blockbuster drugs within the next year. Click here to ...

A new biotech has come roaring to life in Wales with a $140 million series A and a lead candidate ready for phase 2 trials in ...

President Trump is engaged in a whole-of-government assault on American society. So we need a whole-of-society response. The 5 million Americans who took to the streets on June 14 mark an ...

Below is a chart showing JNJ's trailing twelve month trading history, with the $155.00 strike highlighted in red: Considering the fact that the $155.00 strike represents an approximate 1% premium ...

A California-based CEO says he has gotten rid of his health monitoring devices and muted age-obsessed founder Bryan Johnson ...

Forbes' World's Most Influential CMOs list recognizes fifty chief marketers from around the world whose approach to driving ...

If you’re looking for a lesser-known player for whom to root at this week’s U.S. Open, Chase Johnson isn’t a bad option.

Major global pharmaceutical companies traded lower in the premarket on Tuesday after President Donald Trump reiterated his ...

For the second consecutive year, the Chicago Bears are No. 1 on the list with hopes of ascending in the NFC. Here is the list ...

The rapper formerly known as Kanye West, one of the few celebrities to publicly defend Mr. Combs, was denied access to the ...